These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Augmentation of antitumor immunity in cancer chemotherapy]. Author: Hosokawa M, Kobayashi H. Journal: Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1402-6. PubMed ID: 1697151. Abstract: Cancer chemotherapeutic drugs (antitumor drugs) generally inhibit host immune responses to cancer cells. Some antitumor drugs, however, can augment antitumor immune responses if they were administered appropriately. The immuno-augmentation brought about by antitumor drugs might concrete the effects of cancer chemotherapy. The authors introduced their experiments in which they have observed a typical BRM-like effects of bleomycin on tumor-bearing rats and discussed the significance of immuno-augmenting effects of antitumor drugs in cancer chemotherapy.[Abstract] [Full Text] [Related] [New Search]